Viewing Study NCT05089734


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2025-12-31 @ 7:13 PM
Study NCT ID: NCT05089734
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-23
First Post: 2021-10-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Gilead Sciences
Organization: